XML 56 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 2 - Acquisitions of Businesses (Tables)
 12 Months Ended
Dec. 31, 2014
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the consideration transferred and transaction related costs incurred to acquire MacDermid, Agriphar and CAS and the amounts of identified assets acquired and liabilities assumed at the acquisition date:
 (amounts in millions)
 
MacDermid
 
Agriphar
 
CAS
Consideration
 
 
 
 
 
 
Cash, net
 
$
916.5

 
$
350.2

 
$
983.1

Equity Instruments
 
115.4

 
16.6

 
52.0

Long-term debt
 
754.2

 
—

 
—

Derivative liability
 
—

 
3.5

 
—

Contingent Consideration
 
35.5

 
—

 
—

Total Consideration
 
1,821.6

 
370.3

 
1,035.1

 
 
 
 
 
 
 
Transaction related costs
 
15.2

 
4.2

 
33.9

 
 
 
 
 
 
 
Identifiable Assets acquired and Liabilities Assumed
 
 

 
 

 
 

Accounts receivable
 
147.4

 
57.6

 
150.7

Inventories
 
115.3

 
41.5

 
129.3

Other current assets
 
26.2

 
1.6

 
15.5

Property, plant and equipment
 
140.9

 
31.7

 
11.6

Identifiable intangible assets
 
729.0

 
183.0

 
534.0

Other assets
 
28.3

 
5.4

 
21.5

Current Liabilities
 
(117.9
)
 
(48.3
)
 
(69.9
)
Non-current deferred tax liability
 
(171.2
)
 
(64.9
)
 
(25.3
)
Other long term liabilities
 
(66.6
)
 
(15.9
)
 
(13.3
)
Total identifiable net assets
 
831.4

 
191.7

 
754.1

 
 
 
 
 
 
 
Goodwill
 
990.2

 
178.6

 
281.0

 
 
 
 
 
 
 
Total purchase price
 
$
1,821.6

 
$
370.3

 
$
1,035.1
Business Acquisition, Pro Forma Information
The following unaudited pro forma summary presents consolidated information of the Company as if the Agriphar and CAS acquisitions had occurred on January 1, 2013:
 
 (amounts in millions)
 
Revenue
 
Net Income (Loss)
attributable to
Shareholders
 
 
 
 
 
Pro Forma Year Ended 12/31/14
 
$
1,405.9

 
$
46.4

 
 
 
 
 
Pro Forma Year Ended 12/31/13
 
$
731.8

 
$
(229.5
)